A randomized clinical trial on sentinel lymph node dissection versus axillary dissection: A matter of technique

Annals of Surgery

Volumn 247, Issue 2, 2008, Pages 214-216

  Kruper, Laura ^a   Giuliano, Armando E ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; EDITORIAL; HUMAN; JOINT LIMITATION; LYMPH NODE DISSECTION; LYMPHEDEMA; MICROMETASTASIS; MORBIDITY; PARESTHESIA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE DISSECTION; SEROMA; SURGICAL TECHNIQUE;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 38549164622     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318163ff11     Document Type: Editorial

References (15)

1. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394-401.
2. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: A multicenter validation study. N Engl J Med. 1998;339:941-946.
3. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703-7720.
4. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early stage breast carcinoma. Cancer. 2005;106:4-16.
5. Zavagno G, De Salvo GL, Scalco G, et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer. Results of the Sentinella/Givon trial. Ann Surg. 2007;247:207-213
6. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-553.
7. Krag D, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet. 2007;1- 8.
8. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol. 2005;13:491-500.
9. Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg. 2001;233:51-59.
10. Cox CE, Salud CJ, Cantor A, et al. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg. 2001;193:593-600.
11. Tafra L, McMasters KM, Whitworth P, et al. Credentialing issues with sentinel lymph node staging for breast cancer. Am J Surg. 2000;180:268-273.
12. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. J Natl Cancer Inst. 2006;98:599-609.
13. Goyal A, Newcombe RG, Chhabra A, et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203-208.
14. Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol. 2005;23:4312-4321.
15. Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomized controlled study. Lancet. 2006;7:983-90.